These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Synthesis and anticonvulsant and sedative-hypnotic activity of 4-(alkylimino)-2,3-dihydro-4H-1-benzopyrans and -benzothiopyrans. Arnoldi A; Bonsignori A; Melloni P; Merlini L; Quadri ML; Rossi AC; Valsecchi M J Med Chem; 1990 Oct; 33(10):2865-9. PubMed ID: 2213838 [TBL] [Abstract][Full Text] [Related]
5. [Diamino-1,3,5-triazine derivatives. IV. Synthesis and hypoglycemic properties of various 6-amino-1,2-dihydro-4-(5-methyl-2-pyrazoline)-1,3,5-triazine derivatives]. Gajewski F; Rogulski J; Pacanis A Acta Pol Pharm; 1983; 40(5-6):537-44. PubMed ID: 6677069 [No Abstract] [Full Text] [Related]
6. [Diamino-1,3,5-triazine derivatives. V. Synthesis and hypoglycemic properties of various 6-amino-1,2-dihydro-4(5-ethyl-4-methyl-2-pyrazoline)-1,3,5-triazine derivatives]. Gajewski F; Kamiński Z; Pacanis A; Rogulski J Acta Pol Pharm; 1983; 40(5-6):545-9. PubMed ID: 6677070 [No Abstract] [Full Text] [Related]
7. [Quinazolinones. 5. Synthesis of 3-(chloroacylamino)-methyl-4(3H)-quinazolinone derivatives with anticonvulsant and hypnotic activities]. Büyüktimkin S Arch Pharm (Weinheim); 1986 Oct; 319(10):933-9. PubMed ID: 3789900 [No Abstract] [Full Text] [Related]
8. [Parsalmide: a new anti-inflammatory agent. IV. Study on its sedative-tranquilizing and myorelaxant activity]. Francia GC; Ferrero E; Giudice A; Guzzon V Boll Chim Farm; 1976 Feb; 115(2):157-74. PubMed ID: 949358 [No Abstract] [Full Text] [Related]
9. The sedative-hypnotic properties of quazepam, a new hypnotic agent. Barnett A; Iorio LC; Ongini E Arzneimittelforschung; 1982; 32(11):1452-6. PubMed ID: 6129856 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological study of 2-ethyl-4-ethylamino-6-methoxy-s-triazine, a new compound with both central sympathetic and parasympathetic stimulating properties. Chiba S; Saji Y; Hibino H; Takeo Y; Yui T Arzneimittelforschung; 1968 Mar; 18(3):303-9. PubMed ID: 4386816 [No Abstract] [Full Text] [Related]
13. Quinazolines and 1,4-benzodiazepines. 58. The azido group, a novel pharmacophoric substitutent. 7-Azido-5-phenyl-1,4-benzodiazepines. Ning RY; Sternbach LH; Pool W; Randall LO J Med Chem; 1973 Aug; 16(8):879-82. PubMed ID: 4795700 [No Abstract] [Full Text] [Related]
14. Pharmacologic studies with triflubazam (ORF 8063): a new psychotherapeutic agent. Heilman RD; Bauer EW; Da Vanzo JP Curr Ther Res Clin Exp; 1974 Sep; 16(9):1022-32. PubMed ID: 4154182 [No Abstract] [Full Text] [Related]
16. [Diamino-1,3,5 triazine derivatives. VII. Synthesis and various pharmacological properties of 2- amino-4-(3-aminopropyl)-6-(3,5,5-trimethyl- 2-pyrazoline)-1,3,5-triazine]. Brzozowski Z; Pomarnacka E; Filczewski M; Kosmala M; Oledzka K Acta Pol Pharm; 1987; 44(6):481-5. PubMed ID: 3454111 [No Abstract] [Full Text] [Related]
17. [Diamino-1,3,5-triazine derivatives. III. Synthesis and diuretic properties of various 2,4-diamino-6-(sulfamylphenyl)-1,3,5-triazines]. Brzozowski Z; Kamiński Z; Angielski S Acta Pol Pharm; 1981; 38(1):1-9. PubMed ID: 7315457 [No Abstract] [Full Text] [Related]
18. Irreversible enzyme inhibitors. CLXXIX. Active-site-directed irreversible enzyme inhibitors of dihydrofolate reductase from 1-(3-chlorophenyl)-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine with oxyamide bridges to a terminal sulfonyl fluoride. Baker BR; Ashton WT J Med Chem; 1970 Nov; 13(6):1165-70. PubMed ID: 5479858 [No Abstract] [Full Text] [Related]
19. [Contribution on the pharmacology of gamma-butyrolactone]. Hampel H; Hapke HJ Arch Int Pharmacodyn Ther; 1968 Feb; 171(2):306-22. PubMed ID: 5685835 [No Abstract] [Full Text] [Related]